The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia

January 2015 in “ Oncology Research and Treatment ”

Dörthe Schaffrin-Nabe, Inge Schmitz, Anke Josten-Nabe, Ulrike von Hehn, R. Voigtmann

scalp cooling chemotherapy-induced alopecia hair loss chemotherapy premenopausal status hair density scalp metastases

TLDR Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

The study from 2015 examined the success of sensor-controlled scalp cooling in preventing hair loss in 226 cancer patients undergoing chemotherapy. It found that scalp cooling was effective in 65% of patients, with the highest success in breast cancer patients and those receiving specific chemotherapy regimens. Factors such as premenopausal status, absence of comorbidities, lack of additional medication, no nicotine use, and high hair density were linked to better outcomes. Hair length and treatment did not significantly affect the results. Side effects were mild with a low dropout rate, and no increased risk of scalp metastases was observed. The authors recommend scalp cooling as a supportive therapy and propose the creation of an international database for further research.

View this study on karger.com →

Discuss this study in the Community →

Cited in this study

11 / 11 results

research Analysis of Quantitative Changes in Hair Growth During Treatment With Chemotherapy or Tamoxifen in Patients With Breast Cancer: A Cohort Study

24 citations , March 2014 in “British Journal of Dermatology”

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

research What Women Want: Quantifying the Perception of Hair Amount - An Analysis of Hair Diameter and Density Changes with Age in Caucasian Women

61 citations , July 2012 in “British Journal of Dermatology”

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

research S1 Guideline for Diagnostic Evaluation in Androgenetic Alopecia in Men, Women, and Adolescents

151 citations , January 2011 in “British Journal of Dermatology”

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

research Androgenetic Alopecia and Cardiovascular Risk Factors in Men and Women: A Comparative Study

110 citations , September 2010 in “Journal of The American Academy of Dermatology”

Hair loss linked to higher heart disease risk in both men and women.

research Hypertension and Aldosterone Levels in Women with Early-Onset Androgenetic Alopecia

45 citations , April 2010 in “British Journal of Dermatology”

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

research Profiling the Response of Human Hair Follicles to Ultraviolet Radiation

53 citations , July 2009 in “Journal of Investigative Dermatology”

UVB radiation harms hair growth and health, causing cell death and other changes in human hair follicles.

research Dissecting the Impact of Chemotherapy on the Human Hair Follicle

99 citations , October 2007 in “The American journal of pathology”

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

research Hair Loss, Insulin Resistance, and Heredity in Middle-Aged Women: A Population-Based Study

49 citations , June 2003 in “European journal of cardiovascular prevention & rehabilitation”

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

research Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study

56 citations , June 2001 in “European journal of cardiovascular prevention & rehabilitation”

Early balding linked to higher heart disease risk.

research A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia

127 citations , July 1996 in “Journal of The American Academy of Dermatology”

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

research Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer

39 citations , January 1994 in “European Journal of Cancer”

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

6 / 6 results

research Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss

1 citations , September 2022 in “Journal of The American Academy of Dermatology”

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

research Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss

1 citations , January 2022 in “Dermatology Reports”

Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.

research Time to Loss of Response for Dupilumab in Ophiasis-Pattern Alopecia Areata

2 citations , September 2021 in “JAAD case reports”

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

research A Clinico-Epidemiological Study of Scalp Hair Loss in Children (0–18 Years) in Kota Region, South-East Rajasthan

6 citations , January 2019 in “Indian Journal of Dermatology”

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

research Topical and Intralesional Therapies for Alopecia Areata

36 citations , May 2011 in “Dermatologic therapy”

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

research Alopecia Areata: Clinical Presentation, Diagnosis, and Unusual Cases

109 citations , May 2011 in “Dermatologic Therapy”

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.